Core Laboratories N.V. (CLB) Stake Held by Columbia Partners L L C Investment Management

Columbia Partners L L C Investment Management held its stake in Core Laboratories N.V. (NYSE:CLB) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 67,847 shares of the oil and gas company’s stock at the end of the second quarter. Core Laboratories N.V. comprises 0.9% of Columbia Partners L L C Investment Management’s portfolio, making the stock its 25th largest holding. Columbia Partners L L C Investment Management owned 0.15% of Core Laboratories N.V. worth $6,870,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. ProShare Advisors LLC lifted its position in Core Laboratories N.V. by 2.3% during the 2nd quarter. ProShare Advisors LLC now owns 3,889 shares of the oil and gas company’s stock valued at $394,000 after acquiring an additional 87 shares during the period. Nationwide Fund Advisors lifted its position in Core Laboratories N.V. by 27.6% during the 2nd quarter. Nationwide Fund Advisors now owns 7,881 shares of the oil and gas company’s stock valued at $798,000 after acquiring an additional 1,705 shares during the period. Comerica Securities Inc. lifted its position in Core Laboratories N.V. by 9.1% during the 2nd quarter. Comerica Securities Inc. now owns 2,760 shares of the oil and gas company’s stock valued at $280,000 after acquiring an additional 231 shares during the period. GRT Capital Partners L.L.C. purchased a new position in Core Laboratories N.V. during the 2nd quarter valued at about $644,000. Finally, Alliancebernstein L.P. lifted its position in Core Laboratories N.V. by 18.0% during the 2nd quarter. Alliancebernstein L.P. now owns 2,942 shares of the oil and gas company’s stock valued at $298,000 after acquiring an additional 448 shares during the period.

COPYRIGHT VIOLATION NOTICE: “Core Laboratories N.V. (CLB) Stake Held by Columbia Partners L L C Investment Management” was posted by Chaffey Breeze and is owned by of Chaffey Breeze. If you are viewing this report on another publication, it was illegally stolen and republished in violation of United States & international copyright laws. The original version of this report can be viewed at https://www.chaffeybreeze.com/2017/09/18/core-laboratories-n-v-clb-stake-held-by-columbia-partners-l-l-c-investment-management.html.

Core Laboratories N.V. (NYSE:CLB) traded up 1.54% during mid-day trading on Monday, reaching $98.37. 131,318 shares of the company’s stock were exchanged. Core Laboratories N.V. has a one year low of $86.55 and a one year high of $125.83. The firm has a market capitalization of $4.34 billion, a P/E ratio of 60.35 and a beta of 1.60. The company’s 50-day moving average is $93.15 and its 200 day moving average is $104.31.

Core Laboratories N.V. (NYSE:CLB) last released its quarterly earnings results on Monday, July 24th. The oil and gas company reported $0.52 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.51 by $0.01. The business had revenue of $163.90 million during the quarter, compared to analyst estimates of $168.23 million. Core Laboratories N.V. had a net margin of 11.80% and a return on equity of 49.29%. The company’s quarterly revenue was up 10.7% on a year-over-year basis. During the same period in the prior year, the firm posted $0.35 earnings per share. Equities analysts predict that Core Laboratories N.V. will post $2.00 earnings per share for the current fiscal year.

A number of brokerages recently issued reports on CLB. Royal Bank Of Canada set a $145.00 price target on shares of Core Laboratories N.V. and gave the company a “buy” rating in a research report on Saturday, June 17th. BidaskClub cut shares of Core Laboratories N.V. from a “sell” rating to a “strong sell” rating in a research report on Monday, August 14th. ValuEngine raised shares of Core Laboratories N.V. from a “sell” rating to a “hold” rating in a research report on Friday, August 4th. Morgan Stanley lowered their price target on shares of Core Laboratories N.V. from $130.00 to $125.00 and set an “overweight” rating for the company in a research report on Monday, August 7th. Finally, Zacks Investment Research raised shares of Core Laboratories N.V. from a “sell” rating to a “hold” rating in a research report on Tuesday, September 12th. Three analysts have rated the stock with a sell rating, nine have given a hold rating and five have issued a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus price target of $113.58.

About Core Laboratories N.V.

Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples.

Institutional Ownership by Quarter for Core Laboratories N.V. (NYSE:CLB)

Receive News & Ratings for Core Laboratories N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories N.V. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply